In this study, we found that ATAD2 expression was significantly associated with lymph node metastasis and advanced clinical stage, and revealed the prognostic role of ATAD2 in a relatively large cohort of ESCC patients. This evidence concerns the gene ATAD2 and metastatic malignant neoplasm in the lymph nodes.